Living therapies, made of engineered immune cells – and capable of hunting down cancer, reversing autoimmune disease and ...

At the 2026 Cell-Cell Symposium at UCLA, Partillion Bioscience highlighted its role in advancing a new era of cell-cell interaction mapping. Joe de Rutte, CEO of Partillion Bioscience, presented how ...

Jon Weidanz (left) and Soroush Ghaffari (right) of UTA's IMPRINT Lab with the Beacon Discovery instrument. The University of ...

Researchers from the Earlham Institute, in collaboration with the Department of Biology at the University of Oxford, have ...

A single-cell atlas of brain aging epigenetics has mapped methylation, chromatin, and gene activity changes across 36 cell ...

A tiny crystal chip which uses terahertz radiation to see clearly through a wide range of materials could find applications ...

This Research Topic is the second volume of the “Unraveling Breast Cancer Complexity: Insights from Single-Cell Sequencing and Spatial Transcriptomics” ...

Genovis AB, a leading provider of innovative enzyme technologies, today announces a strategic partnership with Single Cell Discoveries to broaden the application of the SEQURNA® Thermostable RNase Inh ...

Dosing of first patient initiates Phase 1 clinical evaluation of BMS-986506 for the treatment of advanced clear cell renal cell carcinoma, the most common form of kidney cancerTransformative moment in ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that preclinical data from its IL ...

Increasing the efficiency of LNPs as therapeutic vehicles offers promise for better mRNA-based and gene editing treatment ...

Researchers at the Earlham Institute, the University of Edinburgh and Heriot-Watt University analyzed gut cells to understand ...